These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36804599)

  • 21. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD.
    Nag N; Tripathi T
    ACS Chem Neurosci; 2022 Sep; 13(17):2544-2546. PubMed ID: 36001801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD.
    Diaper DC; Adachi Y; Lazarou L; Greenstein M; Simoes FA; Di Domenico A; Solomon DA; Lowe S; Alsubaie R; Cheng D; Buckley S; Humphrey DM; Shaw CE; Hirth F
    Hum Mol Genet; 2013 Oct; 22(19):3883-93. PubMed ID: 23727833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS).
    Vaca G; Martinez-Gonzalez L; Fernandez A; Rojas-Prats E; Porras G; Cuevas EP; Gil C; Martinez A; Martin-Requero Á
    J Neurochem; 2021 Feb; 156(3):379-390. PubMed ID: 32628315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.
    Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR
    Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD.
    Yamashita T; Teramoto S; Kwak S
    Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular dissection of TDP-43 in ALS and FTLD].
    Hasegawa M; Arai T; Nonaka T; Tsuji H; Yamashita M; Hosokawa M; Kametani F; Tamaoka A; Akiyama H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):937-9. PubMed ID: 21921518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FTLD/ALS as TDP-43 proteinopathies].
    Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
    Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
    Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death.
    Foster AD; Flynn LL; Cluning C; Cheng F; Davidson JM; Lee A; Polain N; Mejzini R; Farrawell N; Yerbury JJ; Layfield R; Akkari PA; Rea SL
    Sci Rep; 2021 Jun; 11(1):11474. PubMed ID: 34075102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of TDP-43 phosphorylation in aging and disease.
    Eck RJ; Kraemer BC; Liachko NF
    Geroscience; 2021 Aug; 43(4):1605-1614. PubMed ID: 34032984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.
    Wegorzewska I; Baloh RH
    Neurodegener Dis; 2011; 8(4):262-74. PubMed ID: 21124004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms.
    Scherz B; Rabl R; Flunkert S; Rohler S; Neddens J; Taub N; Temmel M; Panzenboeck U; Niederkofler V; Zimmermann R; Hutter-Paier B
    PLoS One; 2018; 13(5):e0197674. PubMed ID: 29787578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.